Search bioRxiv⌕ Search

Biology subjects

zhao, y.

Publications and source records attributed to zhao, y..

6 recordsLinked to original sources

A Unified Structure-Based Deep-Learning Framework for High-Throughput Screening of Protein-Binding RNAs

Protein-RNA interactions regulate diverse biological processes and are increasingly exploited in therapeutic RNA discovery, but accurate inferences of nucleotide preferences and reliable structure prediction remain challenging. Here, we present PRIS, a unified structure-based deep-learning framework that combines two complementary components: PRISeq for nucleotide probability estimation at each RNA position and PRIScore for residue-nucleotide distance prediction to discriminate native-like from incorrect poses. Both share a feature extractor that integrates an Anti-Symmetric Graph Attention Network (A-GAT) with sparse k-Maximum Inner Product (k-MPI) attention to capture long-range interactions across large graphs. PRIScore improves the selection of native-like protein-RNA predictions generated by AlphaFold3, achieving a top-1 success rate of 81.91% on a docking benchmark, compared to 79.26% for AlphaFold3. The selected structures are then fed into PRISeq, which infers position-specific binding preferences and screens RNA libraries. On a PWM benchmark, PRISeq achieved a mean absolute error (MAE) of 0.75, outperforming FoldX, Rosetta-based scoring functions, and NA-MPNN. In virtual screening against MS2 protein, PRISeq screens 129,248 RNA hairpins within 11.95 seconds, achieving the highest EF0.5% of 14.40, approximately double the best baseline. PRIS also effectively enriches active aptamers against NELF-E and GFP while preserving sequence diversity. By integrating structure selection with binding-preference inference, PRIS provides an efficient framework for large-scale RNA library screening and aptamer design.

bioinformatics↗

ImmunoFusion: A Unified Platform for Investigating RNA-seq-Derived Gene Fusions in Cancer and Immunotherapy

BackgroundGene fusions play a critical role in cancer development by persistently activating kinases or inactivating tumor suppressor genes, leading to altered signal transduction and gene expression regulation. However, their impact on treatment responses remains poorly understood. Although existing cancer databases catalog numerous fusion events or immune checkpoint blockade (ICB) studies, no unified platform integrates gene fusion data across cancer types while linking them to the tumor microenvironment (TME) and patient outcomes. Such integration is essential for elucidating how fusions shape immune responses and for developing improved biomarkers for personalized cancer therapies. MethodsTo address this gap, we constructed the Fusion Immune Atlas (ImmunoFusion), a platform integrating data from TCGA, TARGET, CPTAC, and 29 ICB cohorts (including ICB treatments and other treatment modalities) across diverse cancer types. We identified fusion events from raw RNA-seq data using Arriba and STAR-Fusion, and standardized fusion calls by adapting MetaFusion to the GRCh38 reference genome. Additionally, we curated clinical data and estimated TME signatures and cell fractions using the Immuno-Oncology Biological Research (IOBR) approach. ImmunoFusion was developed using the high-quality Rhino framework for Shiny applications, built on R. ResultsImmunoFusion (https://shiny.zhoulab.ac.cn/ImmunoFusion) encompasses 21,014 clinical samples, serving as a comprehensive RNA-seq-derived gene fusion database and analytical tool. It offers functionalities to investigate fusion breakpoints, confidence scores, frequency patterns, and associations with clinical variables. The platform also enables TME evaluation and interactive exploration of fusions for analyzing tumor immunophenotypes in cancer and immunotherapy contexts. As an illustration, analysis of MTAP fusions in lung cancer cohorts revealed their association with a metabolically depleted, "cold" (immune-suppressive) tumor environment and poorer patient outcomes, pinpointing MTAP fusions as a novel biomarker for treatment selection. ConclusionsImmunoFusion represents a significant advancement, delivering a unified platform to explore the influence of gene fusions on cancer and immune responses. It offers particular value in understanding fusion-driven immunotherapy outcomes, paving the way for more effective therapeutic strategies.

bioinformatics↗

Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studies

The transmembrane fusion (F) protein of RSV plays important roles in RSV pathogenesis as it mediates the fusion between virus and the target cell membrane. During the fusion process, F protein transits from a metastable state (prefusion, preF) to a stable state after merging of virus and cell membranes (postfusion, postF). The majority of highly neutralizing antibodies induced by natural infection or immunization targets the preF form, making it the preferred antigen for vaccine development. Here, we evaluate the mRNA vaccine candidate, STR-V003, which encapsulates the modified mRNA encoding the preF protein in lipid nanoparticles (LNPs). This vaccine demonstrated robust immunogenic in both mice and cotton rats. STR-V003 induced high levels of neutralizing antibodies and RSV preF-specific IgG antibodies, and significantly reduced the RSV viral loads in the lung and nose tissue of challenged animals. In addition, STR-V003 did not have obvious enhancement of lung pathology without causing vaccine enhanced disease (VED). The repeated dose general toxicology studies and local tolerance studies of STR-V003 were evaluated in rats. Therefore, STR-V003 has an acceptable safety profile and robust protective immunity against RSV, and has been approved by the FDA to enter phase I clinical study (NCT06344975).

pharmacology and toxicology↗

STOMAGEN-like Regulates Stomatal Generation Causing Increased Water Use Efficiency during C4 Evolution

C4 photosynthesis optimizes plants carbon and water relations, allowing high photosynthetic rate with low stomatal conductance. Stomata have long been believed as a part of C4 syndrome. However, it remains unclear how stomata traits evolved along the path from C3 to C4. Stomatal patterning was examined in Flaveria genus, a model for studying C4 evolution. Comparative, transgenic and semi-in-vitro experiments were used to study molecular basis that underlies stomatal traits along C4 evolution. Novel results: the evolution from C3 to C4 species through intermediate species is accompanied by a stepwise rather than an abrupt change in the stomatal traits. The initial change occurs near Type II and dramatic change occurs at the C4-like species. On the road to C4, stomata become less in number but bigger in size and changes in stomatal density dominates changes in maximum stomatal conductance (gsmax). The reduction of FSTOMAGEN expression underlies altered gsmax between Flaveria species with different photosynthetic pathways and likely occurs in other C4 lineages. Our study provides insight into the pattern, mechanism and role of stomatal evolution along the road towards C4. This work highlights the stomatal traits in the current C4 evolutionary model and the co-evolution of photosynthetic pathway and stomata.

plant biology↗

Changes in the expression of interleukin-10 in myocardial infarction and its relationship with macrophage activation and cell apoptosis

Currently, the role of IL-10 as an anti-inflammatory factor in the occurrence and development of heart disease is still unclear. This study aimed to observe the dynamic changes in the expression of IL-10 in serum and myocardial tissues, as well as to investigate the relationship of IL-10 expression with macrophage activation and cardiomyocyte apoptosis during the occurrence of myocardial infarction. Mice models with myocardial infarction were prepared by ligating anterior descending branch of the coronary artery. The animals were classified into sham operation group (the control group), as well as groups of myocardial infarction based on days 1, 7, 14 and 28. On days 7 and 14, the cells with positive IL-10 expression were largely distributed in the infarct areas, while cells with positive IL-10 expression were decreased on day 28. Serum IL-10 was significantly positively correlated with IL-10 protein expression in myocardial tissues. Moreover, Bcl-2 and Bax protein expression in myocardial tissues, as well as the ratio of Bcl-2/Bax proteins were gradually elevated with prolonged time of infarction. There were positive correlations between IL-10 and Arginase expressions, and between the expressions of Bcl-2 and Bax proteins. After the occurrence of myocardial infarction, the expression of IL-10 was firstly increased and then decreased in serum and myocardial tissues, and this might affect macrophage activation, phenotypic transformation and the occurrence of cardiomyocyte apoptosis.

cell biology↗

INeo-Epp: T-cell HLA class I immunogenic or neoantigenic epitope prediction via random forest algorithm based on sequence related amino acid features

In silico T-cell epitope prediction plays an important role in immunization experimental design and vaccine preparation. Currently, most epitope prediction research focuses on peptide processing and presentation, e.g. proteasomal cleavage, transporter associated with antigen processing (TAP) and major histocompatibility complex (MHC) combination. To date, however, the mechanism for immunogenicity of epitopes remains unclear. It is generally agreed upon that T-cell immunogenicity may be influenced by the foreignness, accessibility, molecular weight, molecular structure, molecular conformation, chemical properties and physical properties of target peptides to different degrees. In this work, we tried to combine these factors. Firstly, we collected significant experimental HLA-I T-cell immunogenic peptide data, as well as the potential immunogenic amino acid properties. Several characteristics were extracted, including amino acid physicochemical property of epitope sequence, peptide entropy, eluted ligand likelihood percentile rank (EL rank(%)) score and frequency score for immunogenic peptide. Subsequently, a random forest classifier for T cell immunogenic HLA-I presenting antigen epitopes and neoantigens was constructed. The classification results for the antigen epitopes outperformed the previous research (the optimal AUC=0.81, external validation data set AUC=0.77). As mutational epitopes generated by the coding region contain only the alterations of one or two amino acids, we assume that these characteristics might also be applied to the classification of the endogenic mutational neoepitopes also called neoantigens. Based on mutation information and sequence related amino acid characteristics, a prediction model of neoantigen was established as well (the optimal AUC=0.78). Further, an easy-to-use web-based tool INeo-Epp was developed (available at http://www.biostatistics.online/INeo-Epp/neoantigen.php)for the prediction of human immunogenic antigen epitopes and neoantigen epitopes.

immunology↗